€82.10
1.08% yesterday
Paris, Nov 15, 05:35 pm CET
ISIN
FR0004186856
Symbol
VETO
Sector
Industry

Vetoquinol Stock price

€82.10
-4.30 4.98% 1M
-17.90 17.90% 6M
-20.30 19.82% YTD
-4.50 5.20% 1Y
-64.70 44.07% 3Y
+24.70 43.03% 5Y
+45.74 125.80% 10Y
Paris, Closing price Fri, Nov 15 2024
-0.90 1.08%
ISIN
FR0004186856
Symbol
VETO
Sector
Industry

Key metrics

Market capitalization €982.02m
Enterprise Value €840.17m
P/E (TTM) P/E ratio 20.83
EV/FCF (TTM) EV/FCF 11.07
EV/Sales (TTM) EV/Sales 1.56
P/S ratio (TTM) P/S ratio 1.83
P/B ratio (TTM) P/B ratio 1.81
Dividend yield 1.02%
Last dividend (FY23) €0.85
Revenue growth (TTM) Revenue growth 2.32%
Revenue (TTM) Revenue €537.47m
EBIT (operating result TTM) EBIT €61.53m
Free Cash Flow (TTM) Free Cash Flow €75.91m
EPS (TTM) EPS €3.98
P/E forward 18.67
P/S forward 1.82
EV/Sales forward 1.56
Show more

Is Vetoquinol a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,897 stocks worldwide.

Vetoquinol Stock Analysis

Unlock Scores for Free

Analyst Opinions

6 Analysts have issued a Vetoquinol forecast:

2x Buy
33%
3x Hold
50%
1x Sell
17%

Analyst Opinions

6 Analysts have issued a Vetoquinol forecast:

Buy
33%
Hold
50%
Sell
17%

Financial data from Vetoquinol

Income Statement P&L | Balance Sheet | Cash Flow


TTM Annually
Jun '24
+/-
%
537 537
2% 2%
100%
- Direct Costs 469 469
5% 5%
87%
69 69
14% 14%
13%
- Selling and Administrative Expenses - -
- Research and Development Expense - -
-
-
94 94
10% 10%
17%
- Depreciation and Amortization 32 32
3% 3%
6%
EBIT (Operating Income) EBIT 62 62
16% 16%
11%
Net Profit 47 47
20% 20%
9%

In millions EUR.

Don't miss a Thing! We will send you all news about Vetoquinol directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Vétoquinol SA operates as a global animal health company. It supplies drugs and nonmedicinal products for the livestock (cattle and pigs) and pet (dogs and cats) markets. The firm designs, develops and sells veterinary drugs and non-medicinal products in Europe, the Americas and the Asia Pacific region. It also manufactures antibiotic, anti-inflammatory, cardiology, and nephrology drugs. The company was founded by Joseph Frechin in 1933 and is headquartered in Lure, France.

Head office France
CEO Matthieu Frechin
Employees 2,483
Founded 1962
Website www.vetoquinol.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today